Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare PITAVASTATIN (Pitavastatin Calcium) and Rosuvastatin (Crestor) — clinical data, side effects, and patient experiences.
Pitavastatin Calcium · Other
How it works
12.1 Mechanism of Action Pitavastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonat...
Approved for
Crestor · HMG-CoA Reductase Inhibitor (Statin)
How it works
Competitively inhibits HMG-CoA reductase with high affinity. More hydrophilic than atorvastatin, with greater LDL-C lowering potency on a milligram basis.
Approved for
Estimated frequency (%) based on clinical trial data
Based on 1 verified patient review
No data yet
No data yet
Avg. Duration
0 months
0% still taking
Avg. Duration
24 months
100% still taking
PITAVASTATIN is a Other, while Rosuvastatin belongs to the HMG-CoA Reductase Inhibitor (Statin) class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.
Rosuvastatin has an average efficacy rating of 10.0/10 and tolerability of 8.0/10 across 1 patient review. Patient-reported outcomes provide real-world context beyond clinical trials, though individual responses to medication vary significantly..
PITAVASTATIN carries 4 FDA warnings. Rosuvastatin carries 3 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.